TY - JOUR
T1 - Bevacizumab
T2 - Improved survival at what cost?
AU - Kolesar, Jill M.
PY - 2005/5/15
Y1 - 2005/5/15
UR - http://www.scopus.com/inward/record.url?scp=18744383046&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=18744383046&partnerID=8YFLogxK
U2 - 10.1093/ajhp/62.10.1017
DO - 10.1093/ajhp/62.10.1017
M3 - Editorial
C2 - 15901584
AN - SCOPUS:18744383046
SN - 1079-2082
VL - 62
SP - 1017
JO - American Journal of Health-System Pharmacy
JF - American Journal of Health-System Pharmacy
IS - 10
ER -